Eventos

Barcelona Science Park and Wefern organize an event to present NEB.

For almost 50 years, NEB has been a world leader in the discovery and production of reagents for the life science industry. New England Biolab’s enzymology expertise allows us to supply reagents for synthesis of high-quality RNA – form template generation to transcription, to capping, tailing and clean up after the synthesis.

The use of in vitro synthesized RNA has been instrumental in the development of RNA vaccines, and CRISP/Cas9 genome editing tools, generation of pluripotent stem cells, screening of RNA inhibitors, as well as development of RNA amplification-based diagnostics. All these applications require high-yield robust reactions with optimized reaction components.

In this seminar Werfen presents how NEB’s portfolio supports your high-quality (m)RNA synthesis from bench-scale to commercial-scale and enables a seamless transition from research to therapeutic manufacturing.